# PANKU-Lung01 (NCT06382116)

> A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06382116
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
- Conditions: Non-small Cell Lung Cancer
- Interventions: BL-B01D1; Pemetrexed+Cisplatin or Carboplatin
- Enrollment: 432
- Primary outcome: Progression-free survival (PFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 8

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=panku-lung01-nct06382116

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06382116", "email": "<work email>"}; the inbox owner confirms by the emailed link.